![PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany](https://i1.rgstatic.net/publication/337008399_4th_Congress_of_ECCO_-_Inflammatory_Bowel_Diseases_Impact_of_anti-TNF_treatment_on_Extra-intestinal_Manifestations_in_Patients_with_Inflammatory_Bowel_Disease_real_world_data_in_Germany/links/5dc01db392851c818028b1a3/largepreview.png)
PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany
![ECCO 2017: Women treated for precursor of breast cancer can expect to live as long as other women - ecancer ECCO 2017: Women treated for precursor of breast cancer can expect to live as long as other women - ecancer](https://cdn.ecancer.org/6973-m.jpg)
ECCO 2017: Women treated for precursor of breast cancer can expect to live as long as other women - ecancer
![12th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology 12th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology](https://www.esp-pathology.org/_Resources/Persistent/ac53b796218c5b837763c09492b2107fa2791497/170907_v2_ECCO%2717%20Web%20banner_150x100.jpg)
12th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology
![ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach](https://researchoutreach.org/wp-content/uploads/2018/06/Vytenis-Andriukaitis-EU-Health-Commissioner-speaking-at-ECCO2017.jpg)
ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach
![Y-ECCO on X: "Peter Irving bravely tackling difficult realities of #ibd healthcare in cost limited times. Azathioprine monotherapy? Biosimilars? #ecco2017 https://t.co/o27RHHB5zr" / X Y-ECCO on X: "Peter Irving bravely tackling difficult realities of #ibd healthcare in cost limited times. Azathioprine monotherapy? Biosimilars? #ecco2017 https://t.co/o27RHHB5zr" / X](https://pbs.twimg.com/media/C4yzn03WEAMmMjc.jpg:large)
Y-ECCO on X: "Peter Irving bravely tackling difficult realities of #ibd healthcare in cost limited times. Azathioprine monotherapy? Biosimilars? #ecco2017 https://t.co/o27RHHB5zr" / X
![Targeting Disease Progression in Crohn's Disease: Fighting an Unrelenting Enemy - European Medical Journal Targeting Disease Progression in Crohn's Disease: Fighting an Unrelenting Enemy - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2018/01/New-Website-Photographs-.8-940x564.jpg)